Ballicules › Drugs › Moxifloxacin
What it is Fluoroquinolone inhibiting bacterial DNA gyrase; respiratory and intra-abdominal infection.
Why this one The broadest anaerobic and pneumococcal cover of the quinolones, once daily, with excellent tissue penetration.
What limits it Poor urinary exposure makes it the wrong quinolone for UTI. Its prominent QT signal compounds the class tendon and neuropathy risks.
FDA-approved for
community-acquired pneumonia (1999) sinusitis (1999)
FDA label
Read the full label on DailyMed ↗
BOXED WARNING Fluoroquinolone class: disabling/potentially irreversible tendinitis & tendon rupture, peripheral neuropathy, CNS effects (may co-occur); may exacerbate myasthenia gravis (avoid). Reserve for patients with no alternative for acute bacterial sinusitis and acute bacterial exacerbation of chronic bronchitis.
FDA dosing Population Start Target Max
Community-acquired pneumonia (7–14 d) adult 400 mg QD
Uncomplicated skin/skin-structure infection (7 d) adult 400 mg QD
Complicated skin/skin-structure infection (7–21 d) adult 400 mg QD
Complicated intra-abdominal infection (5–14 d) adult 400 mg QD
Plague (10–14 d) adult 400 mg QD
Acute bacterial sinusitis (10 d) adult 400 mg QD
Acute bacterial exacerbation of chronic bronchitis (5 d) adult 400 mg QD
Renal No adjustment needed (including hemodialysis or CAPD)
Hepatic No adjustment needed (Child-Pugh A–C); use caution re QT prolongation in cirrhosis
Instructions Take at least 4 h before or 8 h after products with magnesium, aluminum, iron, or zinc (antacids, sucralfate, multivitamins, buffered didanosine) May take with or without food; drink fluids liberally IV-to-oral switch needs no dose change
Contraindications Hypersensitivity to any quinolone antibacterial (class cross-reactivity)
Cautions QT prolongation / torsade de pointes — avoid with QT-prolonging drugs and proarrhythmic conditions Serious/fatal hypersensitivity and anaphylaxis Aortic aneurysm and dissection risk C. difficile-associated diarrhea Blood glucose disturbances Photosensitivity/phototoxicity
Adverse reactions Nausea Diarrhea Headache Dizziness Vomiting Insomnia
Pregnancy No human data; animal studies suggest possible fetal harm
Lactation Unknown if present in human milk; likely excreted (animal data)
⚠ BOXED WARNINGS
Tendinitis and tendon rupture, peripheral neuropathy, CNS effects Exacerbation of myasthenia gravis
Cost, est. cash $10–$500/month
Generic entry By 2023
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 2 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 3 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category C
Defining liability Tendon/aortic injury, dysglycemia and CNS effects; QT or CYP1A2 risk varies by agent.
Mechanism of action: Moxifloxacin ballicule
Open Moxifloxacin in the interactive console ↗
Memory aids: mascots and interaction avatars
“Moxie flocks to Ava’s locks” QT prolongation
Box: minimal PK interactions
Open Moxifloxacin in the interactive console ↗